KR102313373B1 - Composition comprising fermented Poncirus trifoliata extract with both of antimicrobial and antifungal activity and methods of preparation thereof - Google Patents
Composition comprising fermented Poncirus trifoliata extract with both of antimicrobial and antifungal activity and methods of preparation thereof Download PDFInfo
- Publication number
- KR102313373B1 KR102313373B1 KR1020180130289A KR20180130289A KR102313373B1 KR 102313373 B1 KR102313373 B1 KR 102313373B1 KR 1020180130289 A KR1020180130289 A KR 1020180130289A KR 20180130289 A KR20180130289 A KR 20180130289A KR 102313373 B1 KR102313373 B1 KR 102313373B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- antibacterial
- penicillium
- bacteria
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 11
- 239000000284 extract Substances 0.000 title claims description 95
- 238000000034 method Methods 0.000 title claims description 12
- 230000000843 anti-fungal effect Effects 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title description 4
- 241001522083 Citrus trifoliata Species 0.000 title 1
- 235000000404 Poncirus trifoliata Nutrition 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 96
- 241000894006 Bacteria Species 0.000 claims abstract description 74
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 239000002537 cosmetic Substances 0.000 claims abstract description 13
- 241000193755 Bacillus cereus Species 0.000 claims abstract description 11
- 241000588724 Escherichia coli Species 0.000 claims abstract description 11
- 241000186779 Listeria monocytogenes Species 0.000 claims abstract description 10
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 10
- 229940055019 propionibacterium acne Drugs 0.000 claims abstract description 10
- 241000589875 Campylobacter jejuni Species 0.000 claims abstract description 9
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- 241000555688 Malassezia furfur Species 0.000 claims abstract description 8
- 241000607598 Vibrio Species 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 241000228143 Penicillium Species 0.000 claims description 17
- 241001123663 Penicillium expansum Species 0.000 claims description 6
- 241000985513 Penicillium oxalicum Species 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 241000228150 Penicillium chrysogenum Species 0.000 claims description 3
- 240000000064 Penicillium roqueforti Species 0.000 claims description 3
- 235000002233 Penicillium roqueforti Nutrition 0.000 claims description 3
- 241001136494 Talaromyces funiculosus Species 0.000 claims description 3
- 229940121375 antifungal agent Drugs 0.000 claims 6
- 239000010802 sludge Substances 0.000 claims 1
- 239000003206 sterilizing agent Substances 0.000 claims 1
- 238000000855 fermentation Methods 0.000 abstract description 32
- 230000004151 fermentation Effects 0.000 abstract description 32
- 206010016952 Food poisoning Diseases 0.000 abstract description 16
- 208000019331 Foodborne disease Diseases 0.000 abstract description 16
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 abstract description 11
- 229940004208 lactobacillus bulgaricus Drugs 0.000 abstract description 11
- 241001608472 Bifidobacterium longum Species 0.000 abstract description 9
- 230000003078 antioxidant effect Effects 0.000 abstract description 9
- 229940009291 bifidobacterium longum Drugs 0.000 abstract description 9
- 238000001228 spectrum Methods 0.000 abstract description 9
- 230000002421 anti-septic effect Effects 0.000 abstract description 8
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 230000000968 intestinal effect Effects 0.000 abstract description 6
- 239000000419 plant extract Substances 0.000 abstract description 5
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 48
- 230000000052 comparative effect Effects 0.000 description 27
- 239000004310 lactic acid Substances 0.000 description 24
- 235000014655 lactic acid Nutrition 0.000 description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- 239000003755 preservative agent Substances 0.000 description 14
- 208000001840 Dandruff Diseases 0.000 description 11
- 238000009792 diffusion process Methods 0.000 description 11
- 208000002874 Acne Vulgaris Diseases 0.000 description 10
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 10
- 206010000496 acne Diseases 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 235000013824 polyphenols Nutrition 0.000 description 8
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 240000004307 Citrus medica Species 0.000 description 2
- 241000675108 Citrus tangerina Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 241000589989 Helicobacter Species 0.000 description 2
- 244000131316 Panax pseudoginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 241001523486 Poncirus Species 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 150000002338 glycosides Chemical group 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 229930013915 (+)-catechin Natural products 0.000 description 1
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- NLAWPKPYBMEWIR-SKYQDXIQSA-N (2S)-poncirin Chemical compound C1=CC(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 NLAWPKPYBMEWIR-SKYQDXIQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 241001263478 Norovirus Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- NLAWPKPYBMEWIR-VGQRFNKBSA-N Poncirin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C[C@@H](c3ccc(OC)cc3)Oc2c1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 NLAWPKPYBMEWIR-VGQRFNKBSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000736285 Sphagnum Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940060038 chlorine Drugs 0.000 description 1
- 235000017168 chlorine Nutrition 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940079360 enema for constipation Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229940107702 grapefruit seed extract Drugs 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000008858 ponciretin Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000006150 trypticase soy agar Substances 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3472—Compounds of undetermined constitution obtained from animals or plants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/36—Rutaceae [Rue family], e.g. lime, orange, lemon, corktree or pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/02—Antioxidant
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/10—Preserving against microbes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
본 발명은 항균 및 방부 활성을 갖는 식물 추출물을 포함하는 조성물 및 제조방법에 관한 것으로, 더욱 상세하게는 탱자의 2단계 발효를 통해 항균성을 증진시켜 식중독균 등 유해세균에 대해 항균 및 방부 활성을 갖는 조성물과 제조방법, 그리고 이의 용도를 제공하는 것이다.
상기 2단계 발효에 의한 조성물은 비브리오균(Vibrio parahaemolyticus), 황색포도상구균(Staphylococcus aureus), 살모넬라균(Salmonella enteritidis), 대장균(Escherichia coli), 캄필로박터균(Campylobacter jejuni), 리스테리아균(Listeria monocytogenes), 바실러스 세레우스(Bacillus cereus) 등 식중독균에 대해 강한 항균력을 가질 뿐 아니라 여드름균(Propionibacterium acne), 비듬균(Pityrosporum ovale) 등에 대해서도 광범위한 항균 스펙트럼을 나타내고, 장내 유익균인 유산균류(Bifidobacterium longum , Lactobacillus bulgaricus)에는 항균성이 적고 또한 항산화능을 가져 각종 식품, 화장품 또는 생활용품에 적용이 가능하다.The present invention relates to a composition and manufacturing method comprising a plant extract having antibacterial and antiseptic activity, and more particularly, to a composition having antibacterial and antiseptic activity against harmful bacteria such as food poisoning bacteria by enhancing antimicrobial activity through two-step fermentation of tangja and manufacturing methods, and uses thereof.
The composition by the two-step fermentation is Vibrio ( Vibrio). parahaemolyticus ), Staphylococcus aureus , Salmonella enteritidis , Escherichia coli , Campylobacter jejuni ), Listeria monocytogenes ), Bacillus cereus ), as well as strong antibacterial activity against food poisoning bacteria such as Propionibacterium acne , Pityrosporum ovale ), etc., also exhibit a broad antibacterial spectrum, and beneficial intestinal bacteria such as Bifidobacterium longum , Lactobacillus bulgaricus ) has low antibacterial and antioxidant properties, so it can be applied to various foods, cosmetics, or daily products.
Description
본 발명은 탱자를 2단계로 발효시켜 항균력을 증진시킴으로써, 비브리오균(Vibrio parahaemolyticus), 황색포도상구균(Staphylococcus aureus), 살모넬라균(Salmonella enteritidis), 대장균(Escherichia coli), 캄필로박터균(Campylobacter jejuni), 리스테리아균(Listeria monocytogenes) 바실러스 세레우스(Bacillus cereus) 등 식중독균에 대해 강한 항균력을 가질 뿐 아니라 여드름균(Propionibacterium acne), 비듬균(Pityrosporum ovale) 등에 대해서도 광범위한 항균 스펙트럼을 나타내고, 장내 유익균인 유산균류(Bifidobacterium longum , Lactobacillus bulgaricus)에는 항균성이 적은 식물 추출물 조성물 및 이의 제조 방법에 관한 것이다.The present invention enhances antibacterial activity by fermenting tangja in two steps, Vibrio parahaemolyticus , Staphylococcus aureus , Salmonella enteritidis , Escherichia coli , Campylobacter jejuni ), Listeria monocytogenes ) has strong antibacterial activity against food poisoning bacteria such as Bacillus cereus , as well as Propionibacterium acne , Pityrosporum ovale ), etc., also exhibit a broad antibacterial spectrum, and beneficial intestinal bacteria such as Bifidobacterium longum , Lactobacillus bulgaricus ) relates to a plant extract composition with less antibacterial activity and a method for preparing the same.
소득 수준이 향상되면서 위생관념이 철저해지고 있는 추세이나 식중독 사고는 여전히 전세계적으로 주요 사망 원인이 되고 있다. 식중독 발생 추이를 살펴보면 최근에는 계절에 관계없이 연중 발생하며, 특히 겨울철에도 환자수가 줄어들지 않고 있다. 여름철에는 주로 살모넬라, 황색포도상구균, 장염 비브리오균 등의 다양한 원인균이 검출되고, 10-12월의 겨울철에도 노로바이러스와 함께 다양한 원인균 등이 다수 검출되는 추세이다. 따라서 최근 식약처에서도 식품내 유해 미생물에 대한 규격을 더욱 강화하고 있으며 항균 보존제의 역할이 더욱 중요시 되고 있다. As income levels rise, hygiene practices are becoming stricter, but food poisoning accidents are still the leading cause of death worldwide. Looking at the trend of food poisoning, recently, it occurs year-round regardless of the season, and the number of patients has not decreased, especially in winter. In summer, various causative bacteria such as Salmonella, Staphylococcus aureus, and Vibrio enteritis are mainly detected, and in the winter of October-December, various causative bacteria are detected along with norovirus. Therefore, the Ministry of Food and Drug Safety has recently strengthened the standards for harmful microorganisms in food, and the role of antibacterial preservatives is becoming more important.
또한 화장품, 생활용품 분야에서도 미생물에 오염된 제품은 성분의 변질에 따른 기능저하는 물론 피부 발진, 염증등 피부 트러블과 미생물 감염의 위험성을 가지며, 화장품 제품의 특성상 사용기간이 수개월에서 수년까지 길기 때문에 항균 보존제의 역할은 매우 중요하다. 더욱이 여드름균, 비듬균 등에 의한 피부 트러블을 위해서는 이들을 억제할 수 있는 여러 성분들이 사용되고 있다. In addition, in the cosmetics and household products field, products contaminated with microorganisms have a risk of skin troubles such as skin rash and inflammation and microbial infection as well as functional deterioration due to deterioration of ingredients. The role of antimicrobial preservatives is very important. Moreover, for skin troubles caused by acne bacteria and dandruff bacteria, various ingredients that can suppress them are used.
식품에서 항균, 방부제는 그 편의성과 비용 때문에 benzoic acid, nitrite, sorbic acid, sodium metabisulfite, 염소제 등 다양한 합성 보존료가 장기간 사용되어 왔다. 또 현재 화장품이나 생활용품에서도 paraben류 (ester of hydroxybenzoic acid), phenoxyethanol, imidazolidinyl urea, diazolidinyl urea, sorbic acid, triclosan 등의 합성 성분들이 단독 또는 혼합으로 사용되어 왔고, 또 별도로 여드름균, 비듬균 등을 억제하기 위해서는 salicylic acid, benzoyl peroxide 등이 사용되어 왔다. In food, various synthetic preservatives such as benzoic acid, nitrite, sorbic acid, sodium metabisulfite, and chlorine have been used for a long time because of their convenience and cost. In addition, synthetic ingredients such as paraben (ester of hydroxybenzoic acid), phenoxyethanol, imidazolidinyl urea, diazolidinyl urea, sorbic acid, and triclosan have been used alone or in combination in cosmetics and household products. For this purpose, salicylic acid, benzoyl peroxide, etc. have been used.
이러한 합성 항균 보존제들은 사용이 간편하고 항균, 방부 효과가 우수하기 때문에 대부분의 식품, 화장품과 생활용품에서 사용되고 있으나, 최근 합성 방부제의 각종 문제점 및 부작용이 밝혀지면서 지나치게 광범위한 사용 및 과다한 사용 등의 위험성이 대두되고 있다. 인공 항균 보존제의 문제점으로는, ①피부 자극 또는 알러지 유발 ②암 유발 가능성 (유방암 조직에서 방부성분 검출), ③남성생식력 약화, 여성호르몬 역할 (방부제 관련 연구 다수), ④이외에 중추신경 마비, 유전자변이 유발 등에 대한 가능성이 우려되고 있어 WHO 등에서도 부작용의 위험성을 경고하고 있다. These synthetic antibacterial preservatives are easy to use and have excellent antibacterial and antiseptic effects, so they are used in most foods, cosmetics, and household products. is being discussed The problems with artificial antibacterial preservatives are ① skin irritation or allergy ② potential for cancer (preservative component detection in breast cancer tissue) ③ weakening of male fertility, role of female hormones (many studies related to preservatives), ④ central nerve paralysis, genetic mutations As there are concerns about the possibility of causing the disease, the WHO and others are also warning about the risk of side effects.
수십년간 사용되어온 인공 항균, 방부제가 이런 잠재적 위험성을 갖고 있어, 기존과 다른 종류의 항균, 방부제를 도입하거나 또는 천연에 존재하는 물질 중에서 항균이나 방부 효과를 갖는 물질을 찾아내는 연구가 활발히 진행되고 있다. 천연물에 함유된 succinic, malic, tartaric, benzoic acid 등의 유기산류의 미생물 증식억제작용과 flavonoids, catechin 류의 항균효과가 연구되었으며, 동식물의 조직에 함유된 탄소수 12-18개의 지방산이 효과적인 항균성 물질로 보고되었고, 계란에 함유된 lysozyme, transferrin과 우유에 함유된 lactoferrin, 젖산균이 생성하는 nisin 등의 단백질성 물질이 알려져 있다. 또 우리나라에서 많이 사용되는 향신료인 마늘과 양파의 성분에 의한 항균작용이 연구되었으며, 국내의 다양한 생약재 또는 식물성분에 의한 항균성에 대한 연구가 진행되어, 산사, 황련, 측백, 창출, 석창포의 ethanol 추출물이 그람양성 및 음성세균 모두에 대하여 강한 항균성을 가졌다고 보고되었으며, 상백피 추출물이 Listeria monocytogenes 증식을 저해하는 것으로 보고되었고, 한약재인 오미자, 울금, 자초, 고삼, 감초 등이 항균활성이 있다고 보고되었다. Artificial antibacterial agents and preservatives that have been used for decades have such potential risks, so research is being actively conducted to introduce different types of antibacterial and preservatives, or to find substances with antibacterial or antiseptic effects among natural substances. The microbial growth inhibitory action of organic acids such as succinic, malic, tartaric, and benzoic acid contained in natural products and the antibacterial effect of flavonoids and catechins were studied. Protein substances such as lysozyme and transferrin contained in eggs, lactoferrin contained in milk, and nisin produced by lactic acid bacteria are known. In addition, the antibacterial effect of the ingredients of garlic and onion, which are widely used spices in Korea, has been studied, and the antibacterial properties of various domestic herbal or vegetable ingredients have been studied. It was reported that it had strong antibacterial properties against both Gram-positive and negative bacteria, and it was reported that the extract of sangbaekpi inhibits the proliferation of Listeria monocytogenes , and that herbal medicines such as omija, turmeric, ginseng, ginseng, and licorice have antibacterial activity.
그러나 대부분의 천연 항균 보존료는 합성 보존료에 비해 항균 spectrum 이 작고 항균력이 약해 광범위하게 사용되기 어려운 실정이다. 최근 자몽씨 추출물 등 일부 성분을 이용한 제품이 있으나 주로 해외 원료를 수입하여 사용하고 있으며 국내 제품은 극히 적어, 안전하고 강력하면서도 광범위하고 경제적으로 사용할 수 있는 천연 항균 보존료의 개발은 국내 뿐 아니라 해외 시장 확보도 원활이 할 수 있을 것으로 기대한다. However, most natural antibacterial preservatives have a smaller antibacterial spectrum than synthetic preservatives and have weak antibacterial activity, making it difficult to use them extensively. Recently, there are products that use some ingredients such as grapefruit seed extract, but mainly imported raw materials are used and there are very few domestic products. I hope it can be done smoothly as well.
본 발명자들은 천연물 유래의 항균 소재를 찾아내고 항균력을 증진시킬 수 있는 방법을 연구하던 중, 국내에서 자생하는 식물 종인 탱자가 식중독균에 대해 항균 및 방부 활성이 우수한 것을 확인하고, 특히 이를 2단계로 발효하여 항균성분들의 형성 및 추출을 극대화 함으로써 더욱 항균력이 강하고 항균 스펙트럼 범위가 넓은 활성을 갖는 식물 추출물을 개발하게 되었다.While the present inventors were researching a method for finding antibacterial materials derived from natural products and enhancing antibacterial activity, the present inventors confirmed that the antibacterial and antiseptic activity of tangja, a plant species native to Korea, was excellent against food poisoning bacteria, and in particular, it was fermented in two steps. Thus, by maximizing the formation and extraction of antibacterial components, a plant extract with a stronger antibacterial activity and a broad antibacterial spectrum range was developed.
본 발명의 목적은 항균력이 증진된 천연물 유래의 항균소재를 개발하는 것이다. 보다 상세하게는 비브리오균(Vibrio parahaemolyticus), 황색포도상구균(Staphylococcus aureus), 살모넬라균(Salmonella enteritidis), 대장균(Escherichia coli), 캄필로박터균(Campylobacter jejuni), 리스테리아균(Listeria monocytogenes), 바실러스 세레우스(Bacillus cereus) 등 식중독균에 대해 강한 항균력을 가질 뿐 아니라 여드름균(Propionibacterium acne), 비듬균(Pityrosporum ovale) 등에 대해서도 광범위한 항균 스펙트럼을 나타내고, 장내 유익균인 유산균류(Bifidobacterium longum , Lactobacillus bulgaricus)에는 항균성이 적어 각종 식품뿐 아니라 화장품, 의약품, 농약 또는 생활용품에 적용이 가능한 증진된 항균력을 가지는 조성물과 제조방법, 그리고 이의 용도를 제공하는 것이다.An object of the present invention is to develop an antibacterial material derived from a natural product with enhanced antibacterial activity. More specifically, Vibrio parahaemolyticus , Staphylococcus aureus , Salmonella enteritidis , Escherichia coli ), Campylobacter jejuni ), Listeria monocytogenes , Bacillus cereus , etc., as well as having strong antibacterial activity against food poisoning bacteria such as Propionibacterium acne , Pityrosporum ovale ), etc., also exhibit a broad antibacterial spectrum, and beneficial intestinal bacteria such as Bifidobacterium longum , Lactobacillus bulgaricus ) is to provide a composition and manufacturing method having improved antibacterial activity applicable to various foods as well as cosmetics, pharmaceuticals, pesticides or household products, and its use due to its low antibacterial properties.
상기한 목적을 위하여 본 발명이 제 1 의 형태는 페니실리움 균주에 의해 발효된 탱자 추출물을 포함하는 항균 조성물, 또는 유산균 균주에 의해 발효된 탱자 추출물을 포함하는 항균 조성물, 또는 페니실리움 균주 및 유산균 균주에 의해 2단 발효된 탱자 추출물을 포함하는 항균 조성물이다.For the above purpose, the first aspect of the present invention provides an antibacterial composition comprising an extract fermented by a Penicillium strain, or an antibacterial composition comprising an extract fermented by a lactic acid bacteria strain, or a Penicillium strain and It is an antibacterial composition comprising a tangja extract fermented in two stages by a lactic acid bacteria strain.
상기 탱자는 이에 제한 되는 것은 아니나 생탱지, 지실, 지각으로 이루어진 그룹에서 선택된 어느 하나 일 수 있다. 상기 페니실리움 균주는 Penicillium oxalicum , Penicillium expansum , Penicillium funiculosum, Penicillium chrysogenum , Penicillium glaucum , 및 Penicillium roqueforti 으로 이루어진 그룹에서 선택된 어느 하나 이상의 균주일 수 있다. 상기 유산균은 비피도박테리움 롱검(Bifidobacterium longum)을 포함하는 비피도박테리움 속(Bifidobacterium sp) 균주 및 락토바실러스 불가리쿠스(Lactobacillus bulgaricus)로 이루어진 그룹에서 선택된 어느 하나 이상의 유산균일 수 있다. 상기 균은 이에 제한 되는 것은 아니나 비브리오균(Vibrio parahaemolyticus), 황색포도상구균(Staphylococcus aureus), 살모넬라균(Salmonella enteritidis), 대장균(Escherichia coli), 캄필로박터균(Campylobacter jejuni), 리스테리아균(Listeria monocytogenes), 바실러스 세레우스(Bacillus cereus)의 식중독균에 항균활성을 나타내는 균 또는 프로피오니박테리움 아크네(Propionibacterium acne), 비듬균인 피티로스포룸 오발(Pityrosporum ovale)의 피부 상재 트러블성 균이다. The tangja is not limited thereto, but may be any one selected from the group consisting of saengtaengji, jijil, and crust. The Penicillium strain is Penicillium oxalicum , Penicillium expansum , Penicillium funiculosum, Penicillium chrysogenum , Penicillium glaucum , and Penicillium roqueforti It may be any one or more strains selected from the group consisting of. The lactic acid bacteria may be any one or more lactic acid bacteria selected from the group consisting of Bifidobacterium sp) strains and Lactobacillus bulgaricus , including Bifidobacterium longum. The bacteria are not limited thereto, but Vibrio parahaemolyticus ), Staphylococcus aureus ), Salmonella ( Salmonella enteritidis ), Escherichia ( Escherichia ) coli ), Campylobacter jejuni ), Listeria monocytogenes , Bacillus cereus ), or Propionibacterium acne , Pityrosporum ovale ) is a fungus
상기 조성물은 발효된 탱자 추출물을 0.1 내지 50 중량%로 포함하는 식품, 화장품 또는 스프레이 살균제인 항균 조성물일 수 있다.The composition may be an antibacterial composition that is a food, cosmetic or spray disinfectant containing fermented tangja extract in an amount of 0.1 to 50% by weight.
본 발명의 제 2 의 형태는 탱자 추출물을 페니실리움으로 발효하여 제조하는 것을 특징으로 하는 항균 조성물 제조방법이다. 바람직하게는 상기 탱자 추출물의 건조중량 기준으로 1:1 ~ 1: 0.1의 비율로 물을 가하는 단계 및, 상기 물이 가하여진 탱자 추출물에 전배양한 페니실리움 균주를 접종하여 15 ~ 30 ℃에서, 1 ~ 10 일 동안 발효하여 제조될 수 있다. 상기 탱자 및 균에 대한 설명은 본 발명의 제 1 의 형태의 설명을 참조한다.A second aspect of the present invention is a method for producing an antibacterial composition, characterized in that it is prepared by fermenting a tangja extract with Penicillium. Preferably, adding water in a ratio of 1:1 to 1:0.1 based on the dry weight of the Taengja extract; , can be prepared by fermentation for 1 to 10 days. For the description of the above-mentioned tangja and bacteria, refer to the description of the first aspect of the present invention.
본 발명의 제 3 의 형태는 탱자 추출물을 유산균으로 발효하여 제조하는 것을 특징으로 하는 항균 조성물 제조방법이다. 바람직하게는 상기 탱자 추출물의 건조중량 기준으로 1:1 ~ 1: 10의 비율로 물을 가하는 단계 및, 상기 물이 가하여진 탱자 추출물에 전배양한 유산균 균주를 접종하여 15 ~ 40 ℃에서, 0.5 ~ 5 일 동안 발효하여 제조될 수 있다. 상기 탱자 및 균에 대한 설명은 본 발명의 제 1 의 형태의 설명을 참조한다.A third aspect of the present invention is a method for producing an antibacterial composition, characterized in that it is prepared by fermenting a tangja extract with lactic acid bacteria. Preferably, adding water in a ratio of 1:1 to 1:10 based on the dry weight of the Taengja extract; It can be prepared by fermentation for ~5 days. For the description of the above-mentioned tangja and bacteria, refer to the description of the first aspect of the present invention.
본 발명의 제 4 의 형태는 탱자 추출물을 페니실리움으로 발효시킨 후, 2단계로 유산균으로 발효하여 제조하는 것을 특징으로 하는 항균 조성물 제조방법이다. 바람직하게는 상기 탱자 추출물의 건조중량 기준으로 1:1 ~ 1: 0.1의 비율로 물을 가하는 단계 및, 상기 물이 가하여진 탱자 추출물에 전배양한 페니실리움 균주를 접종하여 15 ~ 30 ℃에서, 1 ~ 10 일 동안 1차 발효하는 단계; 상기 1차 발효물에 1:1 ~ 1: 10의 비율로 비율로 물을 가하는 단계; 및 상기 물이 가여진 1차 발효물에 전배양한 유산균 균주를 접종하고, 15 ~ 40 ℃, 0.5 ~ 5 일 동안 2차 발효하여 제조되어질 수 있다. 상기 탱자 및 균에 대한 설명은 본 발명의 제 1 의 형태의 설명을 참조한다.A fourth aspect of the present invention is a method for producing an antibacterial composition, characterized in that the extract is fermented with Penicillium and then fermented with lactic acid bacteria in two steps. Preferably, adding water in a ratio of 1:1 to 1:0.1 based on the dry weight of the Taengja extract; , primary fermentation for 1 to 10 days; adding water to the primary fermented product in a ratio of 1:1 to 1:10; And it can be prepared by inoculating the pre-cultured lactic acid bacteria strain into the primary fermented product with the water, and performing secondary fermentation at 15 to 40 ° C. for 0.5 to 5 days. For the description of the above-mentioned tangja and bacteria, refer to the description of the first aspect of the present invention.
본 발명에 따른 항균 조성물 제조방법은 이에 추가적인 공정을 포함할 수 있다. 즉 여과하는 단계이거나, 침전시키는 단계, 정제하는 단계 등을 추가적으로 포함할 수 있다. The method for preparing the antimicrobial composition according to the present invention may include an additional process. That is, the filtration step, precipitation step, purification step, etc. may be additionally included.
본 발명에 따른 식물 추출물을 포함하는 조성물은 다양한 식중독균들과 피부 상재균에 대해 폭넓은 항균 스펙트럼을 나타내고, 항산화능이 우수하다. 이러한 조성물은 식품 조성물에 적용이 가능하며, 이외에도 화장품, 의약품 및 생활용품 등의 다양한 분야에서 항균, 방부, 살균 목적으로 유용하게 이용가능하다.The composition comprising the plant extract according to the present invention exhibits a broad antibacterial spectrum against various food poisoning bacteria and skin flora, and has excellent antioxidant activity. Such a composition can be applied to a food composition, and in addition, it can be usefully used for antibacterial, antiseptic, and sterilization purposes in various fields such as cosmetics, pharmaceuticals and household products.
도 1은 확산법에 의한 측정된 대장균에 대한 항균 활성을 보여 준다. 실시예 1, 2, 3, 4에서 제조된 추출물과 무처리군, 대조군(paraben)의 사진이다. A: 실시예 1 추출물; B: 실시예 2 추출물; C: 실시예 3 추출물; D: 실시예 4 추출물.1 shows the antibacterial activity against E. coli measured by the diffusion method. It is a photograph of the extracts prepared in Examples 1, 2, 3, and 4, the untreated group, and the control group (paraben). A: Example 1 extract; B: Example 2 extract; C: Example 3 extract; D: Example 4 extract.
탱자는 운향과(Rutaceae)에 속하는 낙엽관목인 탱자나무 (Poncirus trifoliata Rafinesque)의 과실로 4∼5월에 개화하며 과실은 10월에 황색으로 착색되고 특유의 향기를 지니고 있으나 강한 신맛으로 귤이나 오렌지, 레몬과 같이 생용 하기에는 부적합하다. 한국과 중국을 포함한 동남아시아에서는 미성숙된 탱자를 지실(枳實)이란 명칭의 한약재로 사용하고 있으며, 완숙된 탱자의 껍질만 말린 것을 지각(枳殼)이라 한다. 탱자나무 속 식물의 과실은 약용으로 사용되어 왔으며 지실은 습진 치료제로 쓰고, 지각은 설사 치료제 및 관장에 사용하였다. 이밖에도 건위제나 소화불량, 자궁하수, 내장이완 등에도 사용하였으며, 최근에는 아토피와 구강치료제로 사용 되고 있다. Poncirus (Poncirus) is a deciduous shrub belonging to the Rutaceae family. trifoliata Rafinesque), which blooms from April to May, and the fruit is colored yellow in October and has a unique fragrance, but it is not suitable for raw consumption with tangerines, oranges, and lemons due to its strong sour taste. In Southeast Asia, including Korea and China, immature tangja is used as a medicinal herb with the name of Jisil (枳實), and only the dried skin of ripe tangja is called crust (枳殼). The fruit of the plant of the genus oleracea has been used for medicinal purposes, the twigs are used as a treatment for eczema, and the crust is used for the treatment of diarrhea and enemas. In addition, it has been used for gastric ulcer, indigestion, uterine effusion, and intestinal relaxation, and has recently been used as an oral treatment for atopy.
탱자열매의 주요성분으로는 hesperidin, neohesperidin, naringin 및 cumalin류, terpene류, 정유성분 등이 보고되었으며(Park and Chun, 1969; Oh et al., 1989; Chung et al., 2004). 이러한 성분들과 생체기능과의 상관성에 대해 많은 연구가 수행되고 있다.(Patkar et al., 1979, Fewtrell et al., 1982; Sagi-Eisenberg et al., 1985; Kanemoto et al., 1993; Lee et al., 1996; Lee et al., 2005). Hesperidin, neohesperidin, naringin and cumalins, terpenes, and essential oil components have been reported as major components of dandelion fruit (Park and Chun, 1969; Oh et al., 1989; Chung et al., 2004). Many studies have been conducted on the correlation between these components and biological functions (Patkar et al., 1979, Fewtrell et al., 1982; Sagi-Eisenberg et al., 1985; Kanemoto et al., 1993; Lee). et al., 1996; Lee et al., 2005).
탱자의 항균성에 관한 특허로는, 등록특허 10-1399695에 항생제 내성 균주에 대하여 항균 활성을 나타내는 것을 특징으로 하는 탱자추출 조성물에 대한 것과 등록특허 10-1346412에 비듬균 또는 무좀균에 대한 항진균 활성을 가지는 것을 특징으로 하는 탱자추출 조성물이 있으나, 각각 단순추출물을 특정용도에 대한 것으로만 주장하고 있고, 등록특허 10-0526992에 물추출물에 유산균과 효소를 이용해 만든 헬리코박터 억제기능의 탱자추출발효물, 등록특허 10-0322876 에 지실에서 추출정제된 poncirin에 장내세균 플로라를 배양해 ponciretin을 형성시킨 헬리코박터 억제기능의 추출물 등이 있으나, 한정된 조건에서의 유산균발효 및 헬리코박터라는 균억제 용도에 한정하고 있다. 상기 탱자 추출물들은 특정적 용도로는 사용할 수 있겠으나 식품, 화장품 등에 상업적으로 사용할 수 있는 광범위하고 강력한 방부 또는 항균제로 사용하기는 어려운 것으로 여겨진다. Patents related to antibacterial properties of tangja include: Patent 10-1399695, which relates to an extract of tangja, characterized in that it exhibits antibacterial activity against antibiotic-resistant strains, and Patent 10-1346412 discloses that it has antifungal activity against dandruff or athlete's foot. Although there is a composition for extracting tangja that is characterized by, each claiming that a simple extract is for a specific use only, and registered patent 10-0526992, a fermented fermented fermented extract of Helicobacter pylori with lactic acid bacteria and enzymes in a water extract, registered patent 10 -0322876 There are Helicobacter-inhibiting extracts that form ponciretin by culturing Enterobacteriaceae flora in poncirin extracted and purified from E.-0322876, but it is limited to lactic acid fermentation under limited conditions and the use of Helicobacter-inhibiting bacteria. The Taengja extracts can be used for specific purposes, but it is considered difficult to use as a broad and powerful antiseptic or antibacterial agent that can be commercially used in food, cosmetics, and the like.
한편, 탱자와 같은 운향과 식물들, 즉 감귤, 유자, 오렌지, 자몽 등의 과실은 두꺼운 과피를 가지고 있어 과육을 보호하며, 대부분의 생리활성, 항균 성분인 terpinoid, polyphenol, flavonoid, alkaloid 류 들은 주로 과피에 존재한다. 특히 많은 polyphenol, flavonoid 류는 저장형인 배당체(glycoside) 형태로 존재하며 외부 자극이나 감염시에 활성형인 비당체(aglycone) 형태로 전환하는 경우가 많다. 이에 본 발명자들은 탱자의 항균 성분들이 두터운 과피의 cellulose, pectin 등 고분자 다당 성분들에 의해 잘 용출되지 않으며, 대부분 배당체 형태로서 활성형이 적어 항균성도 약하다는 것을 발견하고, 이를 개선할 경우 기존의 단순한 물추출, 알코올 등의 용매 추출에 의한 것보다 강한 항균력을 나타낼 뿐 아니라 기존보다 광범위한 항균 스펙트럼을 나타내어 다양하게 사용할 수 있음을 확인하여 본 발명을 완성하게 되었다. 즉 본 발명자들은 이들 탱자 재료에 먼저 페니실리움(Penicillium) 속 균주를 이용하여 고상 발효시키고 이어서 이 발효물에 유산균을 액상 발효시키는 2단계 발효과정을 통하면 항균 및 방부능이 더욱 향상되는 것을 확인하였다.On the other hand, rutaceae plants, such as tangerine, citron, citron, orange, and grapefruit, have thick rinds to protect the flesh. present in the pericarp. In particular, many polyphenols and flavonoids exist in the storage type glycoside form, and are often converted to the active form aglycone form upon external stimulation or infection. Accordingly, the present inventors found that the antibacterial components of tangja are not eluted well by the high molecular weight polysaccharide components such as cellulose and pectin of the thick skin, and most of them are glycosides, and the active form is small and the antibacterial properties are weak. The present invention was completed by confirming that it can be used in a variety of ways by not only exhibiting a stronger antibacterial activity than that obtained by extraction of solvents such as water and alcohol, but also exhibiting a broader antibacterial spectrum than before. That is, the present inventors confirmed that antibacterial and antiseptic properties were further improved through a two-step fermentation process in which these tangja materials were first fermented in solid phase using a strain of Penicillium spp. .
본 발명의 탱자 발효는 어린 건조 탱자인 지실, 완숙 탱자 과피인 지각 및 생탱자를 모두 사용할 수 있다. Taengja fermentation of the present invention can use all of the young dried taengjae jisil, the ripe taengja rind of the crust and saengtaengja.
1차 발효로서, 발효균인 페니실리움 균주는 윤향과 과실의 과피를 분해하는 것이면 크게 그 종류를 한정하지 않으며, Penicillium oxalicum , Penicillium expansum , Penicillium funiculosum , Penicillium chrysogenum, Penicillium glaucum , Penicillium roqueforti 등을 사용할 수 있다. 탱자는 건조중량 기준으로 1:1 ~ 1: 0.1의 비율, 바람직하게는 1: 0.5 의 비율로 물을 가하여 물을 흡수한 상태로 만들고 미리 전배양한 페니실리움 균주를 접종하여 고상 발효시킨다. 발효는 15 ~ 30 ℃, 바람직하게는 25 ℃에서 진행하며, 1 ~ 10 일, 바람직하게는 3 일 정도 발효 시킨다. 발효가 끝난 발효물은 멸균 및 혼합을 진행한다. As the primary fermentation, Penicillium strain, which is a fermenting bacterium, is not particularly limited as long as it decomposes yunhyang and fruit peel, and Penicillium oxalicum , Penicillium expansum , Penicillium funiculosum , Penicillium chrysogenum, Penicillium glaucum , Penicillium roqueforti etc. can be used. Tangja is made in a state in which water is absorbed by adding water in a ratio of 1:1 to 1:0.1, preferably 1:0.5 based on dry weight, and inoculated with a pre-cultured Penicillium strain and subjected to solid fermentation. Fermentation is carried out at 15 ~ 30 ℃, preferably 25 ℃, and fermented for 1 to 10 days, preferably about 3 days. The fermented product after fermentation is sterilized and mixed.
2차 발효로서, 발효물은 중량 기준으로 1: 1 1:1 ~ 1: 10의 비율, 바람직하게는 1: 3 의 비율로 물을 가하여 미리 전배양한 유산균 균주를 접종하여 액상 발효시킨다. 발효는 15 ~ 40 ℃, 바람직하게는 30 ℃에서 진행하며, 0.5 ~ 5 일, 바람직하게는 1 일 정도 발효 시킨다. 발효가 끝난 발효물은 멸균 및 혼합을 진행한다. 이때 발효균주인 유산균은 크게 종류를 한정하지는 않으나, 사람이나 동물의 장내에서 유익한 균주로 알려진 비피도박테리움 롱검(Bifidobacterium longum)을 포함하는 비피도박테리움 속(Bifidobacterium sp) 균주, 락토바실러스 불가리쿠스(Lactobacillus bulgaricus)를 포함하는 락토바실러스 속(Lactobacillus sp.) 균주가 효과적이다.As the secondary fermentation, the fermented product is subjected to liquid fermentation by inoculating a lactic acid bacteria strain pre-cultured in advance by adding water in a ratio of 1: 1 1:1 to 1: 10, preferably 1: 3 by weight. Fermentation is carried out at 15 ~ 40 ℃, preferably 30 ℃, 0.5 ~ 5 days, preferably fermented for about 1 day. The fermented product after fermentation is sterilized and mixed. At this time, the lactic acid bacteria, which are fermented strains, are not particularly limited in types, but Bifidobacterium sp) strains, including Bifidobacterium longum , which are known to be beneficial strains in the intestines of humans and animals, Lactobacillus vulgaricus ( Lactobacillus bulgaricus ) containing Lactobacillus genus ( Lactobacillus sp. ) The strain is effective.
2단계 발효에 의해 제조된 발효물은 다음의 정제 방법을 적용하여 정제 할 수 있다. 즉, 발효물은 여과후 흡착수지(adsorption resin) 등을 이용하여 활성성분들을 흡착후 용리함으로써 농축 시키거나, 여과후 농축한 뒤 물을 가하고 냉각함으로써 수용성이 낮은 활성성분들을 침전시키는 방법으로 항균 활성을 갖는 성분들을 정제 및 농축할 수 있다. 회수된 추출물은 통상의 방법으로 건조하거나, 식품용은 20 ~ 90%의 glycerin 수용액, 화장품용은 20 ~ 90%의 1,3-butylene glycol 수용액 등과 같은 폴리올(polyol) 수용액에 용해하여 사용할 수 있다.The fermented product prepared by the two-step fermentation can be purified by applying the following purification method. That is, the fermented product is concentrated by eluting after adsorption of active ingredients using adsorption resin after filtration, or by adding water and cooling after filtration to precipitate active ingredients with low water solubility. It is possible to purify and concentrate the components having The recovered extract can be dried by a conventional method, or dissolved in a polyol aqueous solution such as 20 to 90% glycerin aqueous solution for food and 20 to 90% 1,3-butylene glycol aqueous solution for cosmetics. .
본 발명에 따른 조성물은 다양한 미생물, 특히 식중독 균에 광범위한 항균 활성을 나타낸다. 구체적으로, 상기 조성물은 비브리오균(Vibrio parahaemolyticus), 황색포도상구균(Staphylococcus aureus), 살모넬라균(Salmonella enteritidis), 대장균(Escherichia coli), 캄필로박터균(Campylobacter jejuni), 리스테리아균(Listeria monocytogenes), 바실러스 세레우스(Bacillus cereus) 등 식중독균에 대해 강한 항균력을 나타내었고, 여드름균인 프로피오니박테리움 아크네(Propionibacterium acne), 비듬균인 피티로스포룸 오발(Pityrosporum ovale)과 같은 피부 상재 트러블성 균에 대해서도 항균활성을 나타내어 보다 광범위한 항균 스펙트럼을 나타내었다. The composition according to the present invention exhibits a wide range of antibacterial activity against various microorganisms, particularly food poisoning bacteria. Specifically, the composition is Vibrio parahaemolyticus ), Staphylococcus aureus , Salmonella enteritidis , Escherichia coli ), Campylobacter jejuni ), Listeria monocytogenes , Bacillus cereus , etc., showed strong antibacterial activity against food poisoning bacteria, Propionibacterium acne , acne bacteria, Pityrosporum ovale , dandruff bacteria. It also showed antibacterial activity against trouble-prone bacteria on the skin, showing a broader antibacterial spectrum.
또한 상기 조성물은 장내 유익균인 유산균류(Bifidobacterium longum , Lactobacillus bulgaricus)에는 상대적으로 적은 항균 활성을 나타내었다.In addition, the composition is beneficial intestinal bacteria, lactic acid bacteria ( Bifidobacterium longum , Lactobacillus bulgaricus ) showed relatively little antibacterial activity.
이하 실시예와 실험예를 통하여 본 발명의 내용을 설명하나 본 발명이 이에 국한하는 것은 아니다.Hereinafter, the contents of the present invention will be described with reference to Examples and Experimental Examples, but the present invention is not limited thereto.
비교예comparative example 1: 탱자의 단순 1: Simplicity of Tangja 열수hot water 추출물 제조 extract preparation
재료는 건조된 완숙 탱자인 지각을 사용하였다. 재료 100g에 건조중량대비 10배수 물을 가하고 overnight 정치한 후 믹서기로 조분쇄하고 90℃에서 2시간 열수 추출 하였다. 추출물은 동량의 glycerin을 가한 후 여과 천으로 여과하여 사용하였다. As a material, dried and fully ripened tangyi crust was used. Water 10 times the dry weight was added to 100 g of the material, left overnight, and then coarsely pulverized with a mixer, followed by hot water extraction at 90° C. for 2 hours. The extract was used by adding the same amount of glycerin and then filtering it with a filter cloth.
실시예Example 1: 탱자의 1: Tangja 페니실리움penicillium 발효 추출물 제조 Fermented extract preparation
비교예 1과 같은 건조된 완숙 탱자인 지각을 사용하였다. 재료 100g에 건조중량대비 0.5배수 물을 가하고 미리 전배양한 페니실리움 종균(Penicillium oxalicum)을 1 ml 접종하고 25℃에서 3일간 배양하였다. 발효후 초기 건조중량대비 10배수 물을 가하고 동량의 glycerin을 가한 후 여과 천으로 여과하여 사용하였다. The dried hard-ripened tangja crust as in Comparative Example 1 was used. Penicillium spores (Penicillium) pre-cultured by adding water 0.5 times the dry weight to 100 g of material oxalicum ) was inoculated with 1 ml and cultured at 25° C. for 3 days. After fermentation, 10 times the amount of water compared to the initial dry weight was added, and the same amount of glycerin was added, followed by filtration with a filter cloth.
실시예Example 2: 탱자의 유산균 발효 추출물 제조 2: Manufacture of lactic acid bacteria fermented extract of Tangja
비교예 1과 같은 건조된 완숙 탱자인 지각을 사용하였다. 재료 100g에 건조중량대비 10배수 물을 가하고 overnight 정치한 후 믹서기로 조분쇄하고 멸균한 후, 미리 전배양한 유산균 종균(Lactobacillus bulgaricus)을 1 ml 접종하고 30℃에서 2일간 배양하였다. 발효후 동량의 glycerin을 가한 후 여과 천으로 여과하여 사용하였다.The dried hard-ripened tangja crust as in Comparative Example 1 was used. After adding water 10 times the dry weight to 100 g of the material, and leaving it overnight, coarsely crushed with a mixer and sterilized , 1 ml of pre-cultured lactic acid bacteria ( Lactobacillus bulgaricus ) was inoculated and cultured at 30° C. for 2 days. After fermentation, the same amount of glycerin was added and then filtered with a filter cloth.
실시예Example 3: 탱자의 2단계 발효 추출물 제조 3: Preparation of two-step fermented extract of tangja
비교예 1과 같은 건조된 완숙 탱자인 지각을 사용하였다. 실시예 1와 같이, 재료 100g에 건조중량대비 0.5배수 물을 가하고 미리 전배양한 페니실리움 종균(Penicillium oxalicum)을 1 ml 접종하고 25℃에서 3일간 배양하였다. 발효후 실시예 2과 같이 미리 전배양한 유산균 종균(Lactobacillus bulgaricus)을 1 ml 접종하고 30℃에서 2일간 배양하였다. 발효후 동량의 glycerin을 가한 후 여과 천으로 여과하여 사용하였다.The dried hard-ripened tangja crust as in Comparative Example 1 was used. As in Example 1, 0.5 times the dry weight was added to 100 g of the material, and 1 ml of pre-cultured Penicillium spores ( Penicillium oxalicum ) were inoculated and cultured at 25° C. for 3 days. After fermentation, as in Example 2, pre-cultured lactic acid bacteria spawn ( Lactobacillus bulgaricus ) was inoculated with 1 ml and cultured at 30° C. for 2 days. After fermentation, the same amount of glycerin was added and then filtered with a filter cloth.
실험예Experimental example
실험예 1: 확산법에 의한 항균 효능 평가Experimental Example 1: Evaluation of antibacterial efficacy by diffusion method
상기 비교예 1 및 실시예 1 ~ 3에서 얻어진 추출물의 식중독균에 대한 항균 활성 스펙트럼을 조사하기 위해 1차 항균 활성으로서 한천 확산법을 통해 항균 활성을 측정하였다. 식중독균으로서 대장균(Escherichia coli), 바실러스 세레우스(Bacillus cereus)는 각각 Nutrient agar에, 황색포도상구균(Staphylococcus aureus), 비브리오균(Vibrio parahaemolyticus), 살모넬라균(Salmonella enteritidis)는 trypticase soy agar에, 캄필로박터균(Campylobacter jejuni)은 Brucella agar에, 리스테리아균(Listeria monocytogenes)은 Brain heart infusion agar에 배양하였다. 장내 유익균인 유산균은 비피도박테리움 롱굼(Bifidobacterium longum), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus)는 각각 MRS agar 배지에서 배양하였다. 혐기성이 필요한 유산균 등은 anaerobic jar (Gaspak 첨가)을 이용하여 밀봉한 후, 37℃의 배양기에서 배양하였다. In order to investigate the antimicrobial activity spectrum against food poisoning bacteria of the extracts obtained in Comparative Example 1 and Examples 1 to 3, the antibacterial activity was measured through the agar diffusion method as the primary antibacterial activity. As food poisoning bacteria, Escherichia coli ), Bacillus cereus ( Bacillus cereus ) on Nutrient agar, Staphylococcus aureus , Vibrio parahaemolyticus ), Salmonella enteritidis on Nutrient agar, Campylobacter jejuni on trypticase soy agar ( ) on Brucella agar, Listeria monocytogenes ) were cultured on brain heart infusion agar. Lactobacilli, beneficial intestinal bacteria, Bifidobacterium longum, and Lactobacillus bulgaricus were each cultured in MRS agar medium. Lactic acid bacteria that require anaerobic properties were sealed using an anaerobic jar (gaspak added), and then cultured in an incubator at 37°C.
여러 개의 원반 여과지에 기지농도의 추출물 용해액을 묻혀 시험균주가 도포된 고체 한천배지에 올려놓고 배양한 후 원반 주변의 투명대(growth inhibition halo)의 크기를 측정하였다. 이때 투명대가 클수록 항균 활성이 강한 것을 나타내며, 얻어진 결과를 하기 표 1에 나타내었다. 식중독균과 유산균 억제에 대한 대조군으로서는 항균보존료로 널리 사용되는 메틸 파라벤(methyl-paraben) 0.5% 용액을 사용하였다. 확산법에 의한 항균활성의 대표적인 예로 대장균에 대한 항균활성의 그림을 도 1에 나타내었다.After culturing on a solid agar medium coated with the test strain, the extract solution of known concentration was applied to several disk filter papers, and the size of the growth inhibition halo around the disk was measured. In this case, the larger the translucency band, the stronger the antibacterial activity, and the results obtained are shown in Table 1 below. As a control for food poisoning bacteria and lactic acid bacteria inhibition, a 0.5% solution of methyl-paraben, widely used as an antibacterial preservative, was used. As a representative example of the antimicrobial activity by the diffusion method, the figure of the antimicrobial activity against E. coli is shown in FIG. 1 .
[표 1] 확산법에 의한 추출물의 항균 활성 [Table 1] Antibacterial activity of extracts by diffusion method
(투명대 크기 : -; 0mm, +; ∼5mm, ++; 6∼10mm, +++; 11∼15mm, ++++; 15∼20mm, +++++; 20∼ mm)(Transparency band size: -; 0mm, +; ∼5mm, ++; 6∼10mm, +++; 11∼15mm, ++++; 15∼20mm, +++++; 20∼mm)
상기 표 1에 나타낸 바와 같이, 탱자(지각)의 단순 물추출물인 비교예 1 추출물의 경우에는 그람음성균인 대장균, 비브리오균, 살모넬라균 등에 대해 약간의 효과가 있었으나 그람양성균에 대해서는 효과가 그리 크지 않았다. 페니실리움이 발효하여 과피조직이 분해된 실시예 1 추출물의 경우에는 비교예 1 보다 증가된 항균성을 나타내었으며, 유산균만을 발효시켜 추출한 실시예 2 추출물의 경우에는 비교예 1 보다는 항균력이 증가하였지만 실시예 1와 비교해서는 큰 차이를 나타내지 않았다. 반면 2단계 발효에 의한 추출물인 실시예 3 추출물의 경우에는 같은 농도에서 비교예 1, 실시예 1 및 2에 비해 상당히 향상된 항균력을 나타내었다. 이는 일반적으로 사용되는 항균보존료인 파라벤에 비해서도 우수한 것이었다. 이렇게 항균력이 증진된 결과는 2단계 발효의 첫 번째 발효에서 페니실리움균의 작용에 의해 식물조직이 분해되어 식물의 생리활성 성분의 용출이 용이해지고 저분자화된 때문으로 추정되며 또한 이어진 발효에서 유산균 발효에 의해 식물의 페놀 성분 등 항균 성분이 활성구조 또는 미생물 세포에 침투되기 쉬운 저분자 구조로 변환되는 등의 시너지(synergy)효과인 것으로 판단된다. 또 이렇게 항균력이 증가되었음에도 상대적으로 비피더스 및 락토바실러스 등 유산균에 대한 항균성은 크게 증가하지 않은 것은 두 번째 유산균 발효를 통해 유산균에 크게 유해하지 않은 조성이 이루어졌기 때문으로 추정된다. As shown in Table 1, in the case of Comparative Example 1 extract, which is a simple water extract of tangja (earth), there was some effect on gram-negative bacteria such as E. coli, vibrio bacteria, salmonella, etc., but the effect on gram-positive bacteria was not so great. . In the case of the extract of Example 1 in which the pericarp tissue was decomposed by fermentation of Penicillium, it exhibited increased antibacterial activity than in Comparative Example 1, and in the case of the extract of Example 2 extracted by fermenting only lactic acid bacteria, the antibacterial activity was increased compared to that of Comparative Example 1. Compared with Example 1, there was no significant difference. On the other hand, in the case of the extract of Example 3, which is an extract by two-step fermentation, significantly improved antibacterial activity compared to Comparative Examples 1, 1 and 2 at the same concentration. This was superior to parabens, which are commonly used antibacterial preservatives. The result of this increased antibacterial activity is presumed to be because the plant tissue is decomposed by the action of Penicillium bacteria in the first fermentation of the two-step fermentation, which facilitates the elution of the physiologically active components of the plant and makes the molecular weight low. It is judged that it is a synergistic effect such as conversion of antibacterial components such as phenolic components of plants into active structures or low molecular structures that are easy to penetrate into microbial cells by fermentation. In addition, the reason that the antimicrobial activity against lactic acid bacteria such as bifidus and Lactobacillus did not significantly increase despite this increase in antibacterial activity is presumed to be because the composition is not significantly harmful to lactic acid bacteria through the second fermentation of lactic acid bacteria.
실험예Experimental example 2: 액체배양법에 의한 식중독균에 대한 최소 억제 농도 ( 2: Minimum inhibitory concentration for food poisoning bacteria by liquid culture method ( MICMIC ) 결정) decision
본 발명에 따른 조성물의 최소저해농도 (Minimum Inhibition Concentration: MIC)를 측정하기 위해 하기와 같이 수행하였다. 대상 균주들을 실험예 1의 배양배지에서 agar를 뺀 배양배지를 사용하여 전배양한 후, 시료를 배지에 serial dilution하여 준비하고, 전배양한 균액을 약 107 cell/ml이 되도록 접종하였다. 각각의 배양조건에서 배양한 후 미생물 증식 여부를 확인하여, 균이 증식되지 않는 최소 농도(고형분 함량으로 환산)를 MIC로 결정하였다. 식중독균과 유산균 억제에 대한 대조군으로서는 항균보존료로 널리 사용되는 메틸 파라벤(methyl-paraben) 0.5% 용액을 사용하였다. In order to measure the minimum inhibitory concentration (MIC) of the composition according to the present invention, it was carried out as follows. After pre-culturing the target strains using a culture medium excluding agar from the culture medium of Experimental Example 1, the samples were prepared by serial dilution in the medium, and the pre-cultured bacteria were inoculated to about 10 7 cells/ml. After culturing in each culture condition, the growth of microorganisms was checked, and the minimum concentration (converted to solid content) at which the bacteria did not grow was determined as the MIC. As a control for food poisoning bacteria and lactic acid bacteria inhibition, a 0.5% solution of methyl-paraben, which is widely used as an antibacterial preservative, was used.
[표 2] 액체배양법 의한 식물 추출물의 최소억제농도(MIC, 단위 ppm) [Table 2] Minimum inhibitory concentration (MIC, unit ppm) of plant extracts by liquid culture method
상기 표 2에 나타낸 바와 같이, 탱자(지각)의 단순 물추출물인 비교예 1 추출물의 경우에는 전체적으로 그람음성균인 대조군에 비해 비교적 높은 MIC 결과치를 나타내었다. 확산법에서의 결과와 마찬가지로 실시예 1 추출물의 경우에는 비교예 1 보다 증가된 항균성을 나타내었으며, 실시예 2 추출물의 경우에는 비교예 1 보다는 항균력이 증가하였지만 실시예 1와 비교해서는 큰 차이를 나타내지 않았다. 반면 2단계 발효에 의한 추출물인 실시예 3 추출물의 경우에는 같은 농도에서 비교예 1, 실시예 1 및 2에 비해 상당히 향상된 항균력, 즉 적은 MIC 결과치를 나타내었으며 대조군인 파라벤에 비해서도 우수한 것이었다. 또 확산법에서의 결과와 마찬가지로 유산균에 대한 항균성은 크게 증가하지 않았다. As shown in Table 2 above, in the case of Comparative Example 1 extract, which is a simple water extract of tangja (sphagnum), as a whole, a relatively high MIC result was exhibited compared to the gram-negative control group. Similar to the results of the diffusion method, the extract of Example 1 exhibited increased antibacterial properties than Comparative Example 1, and the extract of Example 2 exhibited increased antimicrobial activity than Comparative Example 1, but did not show a significant difference compared to Example 1. . On the other hand, in the case of the extract of Example 3, which is an extract by two-step fermentation, at the same concentration, it exhibited significantly improved antibacterial activity, that is, a small MIC result compared to Comparative Examples 1, 1 and 2, and was superior to the control paraben. Also, as with the results of the diffusion method, the antimicrobial activity against lactic acid bacteria did not significantly increase.
실험예Experimental example 3 : 여드름균에 대한 항균 활성 3: Antibacterial activity against acne bacteria
피부서식 세균 중 여드름의 원인균인 프로피오니박테리움 아크네(Propionibacterium acne)에 대한 항균 활성을 측정하여 얻어진 결과를 하기 표 3, 4에 나타내었다. 여드름 균은 Reinforced Clostridial Medium과 Brain Heart Infusion Medium에 0.1% Tween 80을 첨가한 배지를 사용하였으며, anaerobic jar (Gaspak 첨가)을 이용하여 밀봉한 후, 37℃의 배양기에서 3일 동안 배양하였다. 여드름균 억제에 대한 대조군으로서는 5% benzoyl peroxide을 사용하였다. The results obtained by measuring the antibacterial activity against Propionibacterium acnes , which are the causative bacteria of acne among skin-dwelling bacteria, are shown in Tables 3 and 4 below. Acne bacteria were used in a medium supplemented with 0.1% Tween 80 in Reinforced Clostridial Medium and Brain Heart Infusion Medium, sealed using an anaerobic jar (gaspak added), and then cultured in an incubator at 37°C for 3 days. 5% benzoyl peroxide was used as a control for the inhibition of Acne bacteria.
[표 3] 확산법에 의한 추출물의 여드름균에 대한 항균 활성 [Table 3] Antibacterial activity against acne bacteria of the extract by diffusion method
(투명대 크기 : -; 0mm, +; ∼5mm, ++; 6∼10mm, +++; 11∼15mm, ++++; 15∼20mm, +++++; 20∼ mm)(Transparency band size: -; 0mm, +; ∼5mm, ++; 6∼10mm, +++; 11∼15mm, ++++; 15∼20mm, +++++; 20∼mm)
[표 4] 여드름균에 대한 추출물의 최소억제농도(MIC, 단위 ppm) [Table 4] Minimum inhibitory concentration (MIC, unit ppm) of the extract against Acne acnes
상기 표 3, 4에 나타낸 바와 같이, 여드름균에 대해서 비교예 1 추출물의 경우에는 매우 약한 항균성으로 판단되었으며, 실시예 1와 2 추출물의 경우에는 비교예 1 보다는 항균력이 좋아 대조군과 유사한 항균성을 나타내었다. 반면 2단계 발효에 의한 추출물인 실시예 3 추출물의 경우에는 같은 농도에서 비교예 1, 실시예 1 및 2에 비해 상당히 향상된 항균력, 즉 큰 저해환 형성과 적은 MIC 결과치를 나타내었으며 대조군에 비해서도 매우 우수한 것이었다.As shown in Tables 3 and 4, the extract of Comparative Example 1 against acne bacteria was judged to have very weak antibacterial properties, and in the case of the extracts of Examples 1 and 2, the antibacterial activity was better than that of Comparative Example 1, and thus exhibited antibacterial properties similar to that of the control group. It was. On the other hand, in the case of the extract of Example 3, which is an extract by two-step fermentation, at the same concentration, it exhibited significantly improved antibacterial activity, ie, large inhibitory ring formation and small MIC results, compared to Comparative Examples 1, 1 and 2, and was very excellent compared to the control group. it was
상기 확산법과 MIC 측정법 결과를 참조하면, 본 발명에 따른 조성물은 여드름균에 대해서도 높은 항균 활성을 나타냄을 알 수 있다. Referring to the results of the diffusion method and the MIC measurement method, it can be seen that the composition according to the present invention exhibits high antibacterial activity against acne bacteria.
실험예Experimental example 4: 비듬균에4: To dandruff 대한 항균 활성 antibacterial activity against
비듬균에 대한 항균성을 알아보기 위하여 피티로스포룸 오발(Pityrosporum ovale)을 사용하여 균 성장 억제를 측정하였으며, 얻어진 결과를 하기 표 5, 6에 나타내었다. 비듬균은 피티로스포룸 배지(Malt Extract 6%, Ox-bile 2%, Tween 40 1%, Glycerol mono-oleae 0.25%)를 사용하여 배양하였다. 비듬균 억제에 대한 대조군으로서는 이타코나졸(itaconazole) 0.2%를 사용하였다. Pityrosporum oval (Pityrosporum Oval) to investigate the antibacterial properties against dandruff bacteria ovale ) was used to measure bacterial growth inhibition, and the results obtained are shown in Tables 5 and 6 below. Dandruff was cultured using Ptyrosporum medium (Malt Extract 6%, Ox-bile 2%, Tween 40 1%, Glycerol mono-oleae 0.25%). As a control for the inhibition of dandruff, 0.2% of itaconazole was used.
[표 5] 확산법에 의한 추출물의 비듬균에 대한 항균 활성 [Table 5] Antibacterial activity of extracts by diffusion method against dandruff bacteria
(투명대 크기 : -; 0mm, +; ∼5mm, ++; 6∼10mm, +++; 11∼15mm, ++++; 15∼20mm, +++++; 20∼ mm)(Transparency band size: -; 0mm, +; ∼5mm, ++; 6∼10mm, +++; 11∼15mm, ++++; 15∼20mm, +++++; 20∼mm)
[표 6] 비듬균에 대한 추출물의 최소억제농도(MIC, 단위 ppm) [Table 6] Minimum inhibitory concentration of extract against dandruff (MIC, unit ppm)
상기 표 5, 6에 나타낸 바와 같이, 비듬균에 대해서 비교예 1 추출물의 경우에는 매우 약한 항균성으로 판단되었으며, 실시예 1와 2 추출물의 경우에는 비교예 1 보다는 항균력이 좋아 대조군과 유사한 항균성을 나타내었다. 반면 2단계 발효에 의한 추출물인 실시예 3 추출물의 경우에는 같은 농도에서 비교예 1, 실시예 1 및 2에 비해 상당히 향상된 항균력, 즉 큰 저해환 형성과 적은 MIC 결과치를 나타내었으며 대조군에 비해서도 매우 우수한 것이었다. As shown in Tables 5 and 6, the extract of Comparative Example 1 against dandruff was judged to have very weak antibacterial activity, and in the case of the extracts of Examples 1 and 2, the antibacterial activity was better than that of Comparative Example 1, and thus the antibacterial activity was similar to that of the control. . On the other hand, in the case of the extract of Example 3, which is an extract by two-step fermentation, at the same concentration, it exhibited significantly improved antibacterial activity, ie, large inhibitory ring formation and small MIC results, compared to Comparative Examples 1, 1 and 2, and was very excellent compared to the control group. it was
상기 확산법과 MIC 측정법 결과를 참조하면, 본 발명에 따른 조성물은 비듬균에 대해서도 비교적 높은 항균 활성을 나타냄을 알 수 있다. Referring to the results of the diffusion method and the MIC measurement method, it can be seen that the composition according to the present invention exhibits relatively high antibacterial activity against dandruff.
실험예Experimental example 5: 페놀성 성분의 함량 및 항산화 효과 5: Content of phenolic components and antioxidant effect
각 추출물의 페놀성화합물의 양과 항산화력을 측정하였다. 총 폴리페놀의 함량은 다음과 같은 방법에 의해 측정하였다. 즉 추출조건에 따라 제조된 추출물을 희석한 후, 희석액 5 ml에 folin reagent 5 ml를 가하고 5분간 정치시킨 다음 5 ml의 10% sodium carbonate 용액을 가하였다. 이 혼합액을 1시간 동안 정치한 다음 분광광도계(UV/Vis Spectrophotometer)를 사용하여 760 nm에서 흡광도를 측정하고 (+)catechin을 이용하여 작성한 표준곡선으로부터 총 폴리페놀 함량을 구하였다. 한편 전자 공여작용(elctron donating activity)에 의한 항산화 활성 측정은 DPPH와 같은 안정한 자유 라디칼을 이용하여 LOO 의 model계에서 radical에 대한 항산화물질의 반응성을 라디칼의 감소량이나 감소 속도로부터 직접 평가하는 방법이다. 전자 공여작용은 각 시료 0.2 ml에 4x10-4 M DPPH 용액 (2,2'-diphenyl-picrylhydrazyl)을 첨가한 후 10초간 진탕하고 10분 후 분광광도계(UV/VIS spectrophotometer)를 사용하여 525nm에서 흡광도를 측정하였다. 이때 전자공여 효과는 시료 첨가구와 시료 무첨가군의 흡광도 차이를 백분율로 계산하였다. 폴리페놀 함량과 항산화 활성의 결과는 아래 표 7에 나타내었다.The amount of phenolic compounds and antioxidant power of each extract were measured. The total polyphenol content was measured by the following method. That is, after diluting the extract prepared according to the extraction conditions, 5 ml of folin reagent was added to 5 ml of the diluent, and left for 5 minutes, and then 5 ml of 10% sodium carbonate solution was added. The mixture was allowed to stand for 1 hour, and absorbance was measured at 760 nm using a spectrophotometer (UV/Vis Spectrophotometer), and the total polyphenol content was obtained from a standard curve prepared using (+)catechin. On the other hand, measurement of antioxidant activity by electron donating activity is a method to directly evaluate the reactivity of antioxidants to radicals in the LOO model system from the amount or rate of reduction of radicals using stable free radicals such as DPPH. Electron donation was performed by adding 4x10 -4 M DPPH solution (2,2'-diphenyl-picrylhydrazyl) to 0.2 ml of each sample, shaking for 10 seconds, and using a spectrophotometer (UV/VIS spectrophotometer) after 10 minutes to absorb absorbance at 525 nm was measured. In this case, the electron donating effect was calculated as a percentage of the difference in absorbance between the sample-added group and the sample-free group. The results of polyphenol content and antioxidant activity are shown in Table 7 below.
[표 7] 항산화 활성[Table 7] Antioxidant activity
(0.1 mg/ml)Control: Vitamin C
(0.1 mg/ml)
상기 표 7을 참조하면, 실시예 3 추출물의 폴리페놀 함량 및 항산화력의 수치가 단순추출인 비교예 1 및 단일 발효인 실시예 1, 2 추출물에 비해 월등히 높은 것으로 알 수 있다. 실시예 3 추출물은 전술한 바의 실험 결과에 나타난 바와 같이 식중독균, 피부유해 상재균에 대한 항균 활성이 우수할 뿐만 아니라 항산화능이 있어 식품, 화장품, 생활용품 등의 조성물로서 활용가능한 성분인 것으로 확인되었다. Referring to Table 7, it can be seen that the polyphenol content and antioxidant power of the extract of Example 3 are significantly higher than those of Comparative Example 1, which is a simple extraction, and Examples 1 and 2, which is a single fermentation. As shown in the experimental results of the above-mentioned bar, the extract of Example 3 has excellent antibacterial activity against food poisoning bacteria and skin-harmful flora as well as antioxidant activity, so it was confirmed that it is a component that can be used as a composition for food, cosmetics, household goods, etc. .
이하, 제형예 1 ~ 3을 들어 상기 실시예 3에서 제조된 추출물을 포함하는 식품, 화장품, 스프레이 제품의 조성물 구성을 보다 구체적으로 설명한다. 그러나 본 발명의 조성물이 이들 제형예에 한정되는 것은 아니다.Hereinafter, with reference to Formulation Examples 1 to 3, the composition of food, cosmetics, and spray products containing the extract prepared in Example 3 will be described in more detail. However, the composition of the present invention is not limited to these formulation examples.
제형예Formulation example 1. 식품(음료) 조성물 1. Food (beverage) composition
제형예Formulation example 2. 화장품 ( 2. Cosmetics ( 밀크로션milk lotion ) 조성물) composition
제형예Formulation example 3. 스프레이(주방기구 살균용)3. Spray (for sterilization of kitchen utensils) 조성물 composition
Claims (7)
The composition according to claim 1, wherein the composition is a food, cosmetic or spray sterilizing agent containing fermented tangja extract in an amount of 0.1 to 50% by weight, and has both antifungal and antibacterial activity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180130289A KR102313373B1 (en) | 2016-06-16 | 2018-10-29 | Composition comprising fermented Poncirus trifoliata extract with both of antimicrobial and antifungal activity and methods of preparation thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160075249A KR101943153B1 (en) | 2016-06-16 | 2016-06-16 | Composition comprising fermented Poncirus trifoliata extract with antimicrobial and antiseptic activity and methods of preparation thereof |
KR1020180130289A KR102313373B1 (en) | 2016-06-16 | 2018-10-29 | Composition comprising fermented Poncirus trifoliata extract with both of antimicrobial and antifungal activity and methods of preparation thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160075249A Division KR101943153B1 (en) | 2016-06-16 | 2016-06-16 | Composition comprising fermented Poncirus trifoliata extract with antimicrobial and antiseptic activity and methods of preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180120660A KR20180120660A (en) | 2018-11-06 |
KR102313373B1 true KR102313373B1 (en) | 2021-10-14 |
Family
ID=64329660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180130289A KR102313373B1 (en) | 2016-06-16 | 2018-10-29 | Composition comprising fermented Poncirus trifoliata extract with both of antimicrobial and antifungal activity and methods of preparation thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102313373B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102654908B1 (en) | 2023-11-13 | 2024-04-05 | 주식회사 다온푸드 | Meal kit product available for refrigerated distribution using steamed squid and manufacturing method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102395720B1 (en) * | 2020-03-18 | 2022-05-09 | (주) 셀리버리 리빙앤헬스 | Anti-fungal Composition Containing Sodium Bicarbonate and Skin conditioning agents and Wet wipes Comprising said Composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000046630A (en) * | 1998-12-31 | 2000-07-25 | 성재갑 | Composition containing ponciri fructus extract for treating skin pruritus |
KR100526992B1 (en) * | 2002-08-21 | 2005-11-09 | 주식회사 렉스진바이오텍 | Fermented extract of a fruit of the trifoliate orange, and a composition for treating the disease caused by infection of helicobacter pylori |
KR101399695B1 (en) * | 2012-04-27 | 2014-05-27 | 중앙대학교기술지주 주식회사 | Extract of fruit of Poncirus sp. and/or Gardenia sp. having antimicrobial activity and composition comprising thereof |
KR101614574B1 (en) * | 2012-08-02 | 2016-04-21 | 동아대학교 산학협력단 | Composition of Diabetes-Improving Effective Constituents by Fermentation Products of the Trifoliate Orange |
KR101652317B1 (en) * | 2014-05-27 | 2016-08-31 | 장영웅 | Medicine, drink and cosmetic composition containing fermented solution of trifoliate orange and starch syrup for preventing, treating or relieving inflammatory diseases or allergic diseases |
-
2018
- 2018-10-29 KR KR1020180130289A patent/KR102313373B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102654908B1 (en) | 2023-11-13 | 2024-04-05 | 주식회사 다온푸드 | Meal kit product available for refrigerated distribution using steamed squid and manufacturing method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20180120660A (en) | 2018-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Motshakeri et al. | Nutritional, phytochemical and commercial quality of Noni fruit: A multi-beneficial gift from nature | |
KR101266180B1 (en) | Vegetable antibacterial composition and cosmetic composition for improving skin using the same | |
KR101432584B1 (en) | Method for steamed and fermented Codonopsis lanceolata for boosting biological activity | |
KR20150111724A (en) | Beverage Compositon for Animal Companhaving Antioxidant and Deodorant | |
KR102313373B1 (en) | Composition comprising fermented Poncirus trifoliata extract with both of antimicrobial and antifungal activity and methods of preparation thereof | |
CN104705411A (en) | Novel technology for processing and fresh-keeping of soy product produced by natural organic plant extract formula | |
KR20140121714A (en) | Whitening cosmetic composition and Antibacterial composition containing the extract of Hippophae rhamnoides L. | |
KR20090075282A (en) | Cosmetic composition for the natural preservative from decay containing the extract of the chopi | |
KR101602552B1 (en) | Antimicrobial composition comprising the extract of cornus officinalis | |
KR101349101B1 (en) | Natural germicide composition and methods for manufacturing a natural germicide | |
KR20120061221A (en) | COMPOSITION OF NURAL EXTRACT, JAPANESE SUMAC AND ANEMARRHENA RHIZOME AND Ailanthus altissima AND THEIR USE | |
KR101911847B1 (en) | Antimicrobial composition comprising organic solvent fractions of arctium lappa root extracts as an effective component | |
KR101943153B1 (en) | Composition comprising fermented Poncirus trifoliata extract with antimicrobial and antiseptic activity and methods of preparation thereof | |
KR101063351B1 (en) | The extracts and fractions of Hippophae rhamnoides L. | |
KR102305141B1 (en) | Manufacturing method of instant food salad and instant food salad manufactured by using the same | |
KR102093741B1 (en) | Manufacturing method of instant food salad | |
KR101636608B1 (en) | Composition for antioxidation comprising the seed extract of cornus officinalis | |
Kumar et al. | Functional properties of pomegranate peel in edible coating/film: A review | |
KR101678500B1 (en) | Nature food preserver comprising the extract of Rhus javanica and process method and composition thereof | |
KR101176944B1 (en) | Natural Food Preservatives Containing Licorice Extract, Paeonia Suffruticosa Andrew Extract and Coptis Japonica Makino Extract | |
KR20090046387A (en) | Functional cosmetic composition comprising scutellaria,houttuynia,artemisia,citurs junos extract having antimicrobial activity | |
KR100872582B1 (en) | Functional fresh-cut yam containing natural spice and method for manufacturing thereof | |
KR20110138175A (en) | Natural food preservatives containing paeonia radix extract, cinnamomum cassia blume extract and gallnut extract | |
KR102196276B1 (en) | Probiotic composition comprising green tea fermented extract having antibacterial activity against acne-causing resident skin flora and antioxidant efficacy | |
Abou-Zaid et al. | The Effect of Arak Stems Extracts on Chemical Characteristics, Bacterial Activity and Sensory Evaluation of Beef Sausage Products. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |